PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Cancer Research and Treatment10.4143/crt.2013.45.1.40201345140-47Feasibility of Oxaliplatin, Leucovorin, and 5-Fluorouracil (FOLFOX-4) Chemotherapy in Heavily Pretreated Patients with Recurrent Epithelial Ovarian CancerHee Jun Lee, Hee Seung Kim, Noh Hyun Park, Hyun Hoon Chung, Jae Weon Kim, Yong Sang Songhttp://www.e-crt.org/upload/pdf/crt-45-40.pdf, http://www.e-crt.org/upload/pdf/crt-45-40.pdf
BMC Cancer10.1186/s12885-018-5180-12018181Oxaliplatin plus leucovorin and 5-fluorouracil (FOLFOX-4) as a salvage chemotherapy in heavily-pretreated platinum-resistant ovarian cancerVincenza Conteduca, Giorgia Gurioli, Lorena Rossi, Emanuela Scarpi, Cristian Lolli, Giuseppe Schepisi, Alberto Farolfi, Delia De Lisi, Valentina GallĂ , Salvatore Luca Burgio, Cecilia Menna, Andrea Amadori, Lorena Losi, Dino Amadori, Maria Paola Costi, Ugo De Giorgihttp://link.springer.com/content/pdf/10.1186/s12885-018-5180-1.pdf, http://link.springer.com/article/10.1186/s12885-018-5180-1/fulltext.html, http://link.springer.com/content/pdf/10.1186/s12885-018-5180-1.pdf
Yearbook of Oncology10.1016/s1040-1741(08)70092-720062006128Oxaliplatin Plus High-Dose Leucovorin and 5-Fluorouracil (FOLFOX 4) in Platinum-Resistant and Taxane-Pretreated Ovarian Cancer: A Phase II StudyJ.T. Thigpenhttps://api.elsevier.com/content/article/PII:S1040174108700927?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1040174108700927?httpAccept=text/plain
Chinese Journal of Clinical Oncology10.1007/s11805-007-0397-9200746397-400Oxaliplatin, fluorouracil and leucovorin (FOLFOX) as first-line chemotherapy for metastatic or recurrent colorectal cancer patientsBing Han, Ruihua Xu, Yanxia Shi, Huiyan Luo, Xiaojuan Xiang, Yuhong Li, Li Zhang, Tongyu Lin, Youjian Hehttp://link.springer.com/content/pdf/10.1007/s11805-007-0397-9.pdf, http://link.springer.com/article/10.1007/s11805-007-0397-9/fulltext.html, http://link.springer.com/content/pdf/10.1007/s11805-007-0397-9
Chemotherapy10.1159/0000711442003494194-199Oxaliplatin with Weekly Bolus 5-Fluorouracil and Leucovorin in Pretreated Advanced Colorectal Cancer Patients: A Phase II StudyTsai-Shen Yang, Jinn-Shium Chen, Reiping Tang, Jy-Ming Chiang, Pau-Shiu Hsieh, Chien-Yu Yeh, Chung-Rong Changchienhttps://www.karger.com/Article/Pdf/71144, https://www.karger.com/Article/Pdf/71144
Gynecologic Oncology10.1016/j.ygyno.2004.06.0292004951165-172Oxaliplatin plus high-dose leucovorin and 5-fluorouracil (FOLFOX 4) in platinum-resistant and taxane-pretreated ovarian cancer: A phase II studyDimitrios Pectasides, Melina Pectasides, Dimitrios Farmakis, Asimina Gaglia, Anna Koumarianou, Maria Nikolaou, Maria Koumpou, Panteleimon Kountourakis, Georgios Papaxoinis, Panagiota Mitrou, Theofanis Economopoulos, Sotirios A. Raptishttps://api.elsevier.com/content/article/PII:S009082580400455X?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S009082580400455X?httpAccept=text/plain
Medical Oncology10.1007/s12032-011-9839-62011292418-424Phase II study of oxaliplatin plus leucovorin and 5-fluorouracil in heavily pretreated metastatic breast cancer patientsSi Sun, Lei Ping Wang, Jian Zhang, Xiao Yan Yang, Qun Ling Zhang, Zhen Jia, Xi Chun Hu, Bi Yun Wanghttp://link.springer.com/content/pdf/10.1007/s12032-011-9839-6.pdf, http://link.springer.com/article/10.1007/s12032-011-9839-6/fulltext.html, http://link.springer.com/content/pdf/10.1007/s12032-011-9839-6
Value in Health10.1016/s1098-3015(11)73114-x2010137A514PCN22 ECONOMIC ANALYSIS OF CAPECITABINE PLUS OXALIPLATIN (XELOX) VERSUS FLUOROURACIL/LEUCOVORIN PLUS OXALIPLATIN (FOLFOX) IN THE TREATMENT OF ADVANCED GASTRIC CANCER IN CHINAW Chenhttps://api.elsevier.com/content/article/PII:S109830151173114X?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S109830151173114X?httpAccept=text/plain
Current Oncology10.3390/curroncol2904021620222942644-26495-Fluorouracil/L-Leucovorin Plus Oxaliplatin (FOLFOX) Regimen as Salvage Chemotherapy for Patients with Unresectable Pancreatic Cancer Receiving Gemcitabine and Nab-Paclitaxel and 5-Fluorouracil/L-Leucovorin Plus Nanoliposomal Irinotecan: Preliminary Results from Clinical PracticeTakuo Yamai, Kenji Ikezawa, Yasuharu Kawamoto, Takeru Hirao, Sena Higashi, Kazuma Daiku, Shingo Maeda, Yutaro Abe, Makiko Urabe, Yugo Kai, Ryoji Takada, Tasuku Nakabori, Hiroyuki Uehara, Kazuyoshi Ohkawahttps://www.mdpi.com/1718-7729/29/4/216/pdf
Value in Health10.1016/s1098-3015(11)71961-12010137A263PCN66 ECONOMIC ANALYSIS OF CAPECITABINE PLUS OXALIPLATIN (XELOX) VERSUS FLUOROURACIL/LEUCOVORIN PLUS OXALIPLATIN (FOLFOX) IN THE TREATMENT OF ADVANCED COLON-RECTUM CANCER IN CHINAW Chenhttps://api.elsevier.com/content/article/PII:S1098301511719611?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1098301511719611?httpAccept=text/plain